Brind.

DHR's acquisition of Masimo has been completed, leading to an increase in financial guidance.

4 reports, 4 independent Updated Jul 24
Gone quiet Reached 2 outlets in its first 24 hours
Reports
4
Developments
3
Repetition
25%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 4 independent outlets

DHR's acquisition of Masimo has been completed, leading to an increase in financial guidance.

Who's involved

What this event is mainly about
DHRMasimo

How it developed

Newest first. Tap a step to see who reported it.
  1. The acquisition of Masimo by Danaher is being compared to Nvidia's past growth trajectory.1 source
  2. DHR completed its acquisition of Masimo, leading to guidance increases.1 source
  3. Masimo product receives FDA clearance post-Danaher acquisition.1 source

Keep exploring

The entities involved

  • DHR

    advocacy organization

    Nothing else this week.

  • Masimo

    American healthcare company

    Nothing else this week.

Coverage

Newest first; wire copies grouped